Prevalence and role of efflux pump activity in ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 6, 2011, Pages 745-752

  Aathithan, S ^a   French, G L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CARBON 14; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GLYCINE; PHENYLALANINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SERINE; TYROSINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CELL CYCLE PHASE; CONTROLLED STUDY; DRUG TRANSPORT; EFFLUX PUMP; GENE MUTATION; GENOTYPE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PUMP;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CARBON RADIOISOTOPES; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; STAINING AND LABELING; UNCOUPLING AGENTS;

EID: 79956061702     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-010-1147-0     Document Type: Article

References (42)

1. Bryan J (2008) Ciprofloxacin - not invincible. Pharmaceut J 280:187-188
2. Gootz TD (2006) The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance. Biochem Pharmacol 71:1073-1084
3. Hooper DC (2003) Mechanisms of quinolone resistance. In: Hooper DC, Rubinstein E (eds) Quinolone antimicrobial agents, 3rd edn. ASM Press, Washington DC, pp 41-67
4. Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infect Dis 41:S120-S126
5. Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E (2000) Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 44:1223-1228 (Pubitemid 30228298)
6. Hooper DC (1999) Mode of action of fluoroquinolones. Drugs 58 (Suppl 2):6-10
7. Hooper DC (2001) Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 32:S9-S15
8. Kohler T, Pechere J-C (2000) Bacterial resistance to quinolones: mechanisms and clinical implications. In: Andriole VT (ed) The quinolones, 3rd edn. Academic Press, London, pp 139-167
9. Kumar A, Schweizer HP (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57:1486-1513 (Pubitemid 40984603)
10. Li XZ, Nikaido H (2009) Efflux-mediated drug resistance in bacteria: an update. Drugs 69:1555-1623
11. Lomovskaya O, Zgurskaya HI, Totrov M, Watkins WJ (2007) Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat Rev Drug Discov 6:56-65 (Pubitemid 46020286)
12. Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB (2000) Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 44:10-13 (Pubitemid 30010664)
13. Piddock LJ (2006) Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 4:629-636
14. Piddock LJV (1999) Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58:11-18
15. Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20-51
16. Doménech-Sánchez A, Martínez-Martínez L, Hernández-Allés S, del Carmen Conejo M, Pascual A, Tomás JM et al (2003) Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother 47:3332-3335 (Pubitemid 37229599)
17. Nikaido H, Thanassi DG (1993) Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob Agents Chemother 37:1393-1399 (Pubitemid 23202359)
18. Piddock LJV, Wise R (1986) The effect of altered porin expression in Escherichia coli upon susceptibility to 4- quinolones. J Antimicrob Chemother 18:547-549 (Pubitemid 16030731)
19. Jonas BM, Murray BE, Weinstock GM (2001) Characterization of emeA, a norA homolog and multidrug resistance efflux pump, in Enterococcus faecalis. Antimicrob Agents Chemother 45:3574-3579 (Pubitemid 33107880)
20. Li X-Z, Livermore DM, Nikaido H (1994) Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 38(8):1732-1741 (Pubitemid 24250718)
21. Poole K, Krebes K, McNally C, Neshat S (1993) Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175:7363-7372 (Pubitemid 23339316)
22. Poole K (2000) Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob Agents Chemother 44:2233-2241
23. Deguchi T, Kawamura T, Yasuda M, Nakano M, Fukuda H, Kato H et al (1977a) In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections. Antimicrob Agents Chemother 41:1609-1611
24. Everett MJ, Jin YF, Ricci V, Piddock LJV (1996) Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40:2380-2386 (Pubitemid 26328050)
25. Hasdemir UO, Chevalier J, Nordmann P, Pagès J-M (2004) Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol 42:2701-2706 (Pubitemid 38747524)
26. Hooper DC, Wolfson JS, Souza KS, Ng EY, McHugh GL, Swartz MN (1989) Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation. Antimicrob Agents Chemother 33:283-290 (Pubitemid 19071958)
27. Martínez-Martínez L, Pascual A, del Carmen Conejo M, García I, Joyanes P, Doménech-Sánchez A et al (2002) Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum β-lactamase production. Antimicrob Agents Chemother 46:3926-3932 (Pubitemid 35403270)
28. Martínez-Martínez L, Pascual A, Jacoby GA (1998) Quinolone resistance from a transferable plasmid. Lancet 351:797-799 (Pubitemid 28112342)
29. Mazzariol A, Zuliani J, Cornaglia G, Rossolini GM, Fontana R (2002) AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob Agents Chemother 46:3984-3986 (Pubitemid 35403279)
30. Mortimer PG, Piddock LJ (1991) A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 28:639-653
31. Aathithan S, French GL (2008a) Topoisomerase alterations and ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae. In: Proceedings of the 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, April 2008. Abstract 1641
32. Aathithan S, French GL (2008b) Prevalence of efflux pump activity and its role in ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae. In: Proceedings of the 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, April 2008. Abstract 1557
33. Aathithan S (2008) Mechanisms and genetics of ciprofloxacin resistance in Klebsiella pneumoniae. PhD Thesis, University of London, London
34. Nikaido H (1996) Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 178:5853-5859
35. Nikaido H (1989) Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother 33:1831-1836
36. Brisse S, Milatovic D, Fluit ADC, Verhoef J, Martin N, Scheuring S et al (1999) Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trova-floxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrob Agents Chemother 43:2051-2055 (Pubitemid 29395208)
37. Deguchi T, Fukuoka A, Yasuda M, Nakano M, Ozeki S, Kanematsu E et al (1977b) Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 41:699-701
38. Schneiders T, Amyes SG, Levy SB (2003) Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother 47:2831-2837 (Pubitemid 37040255)
39. Kuete V, Ngameni B, Tangmouo JG, Bolla J-M, Alibert-Franco S, Ngadjui BT et al (2010) Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobava-chalcone and diospyrone. Antimicrob Agents Chemother 54:1749-1752
40. Rosen BP, Kashket ER (1978) Energetics of active transport. In: Rosen BP (ed) Bacterial transport. Marcel Dekker, New York, pp 559-620
41. Yang S, Clayton SR, Zechiedrich EL (2003) Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother 51:545-556 (Pubitemid 36336146)
42. Chen S, Cui S, McDermott PF, Zhao S, White DG, Paulsen I et al (2007) Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar Typhimurium to fluoroquinolones and other antimicrobials. Antimicrob Agents Chemother 51:535-542 (Pubitemid 46185271)